Lucie Lefevre Selected Research

Lucie Lefevre Research Topics

2	Pneumonia (Pneumonitis) 01/2024 - 12/2022
1	Ventilator-Associated Pneumonia 01/2024
1	Critical Illness (Critically Ill) 01/2024
1	Latent Infection 12/2022
1	Healthcare-Associated Pneumonia 12/2022
1	Human Influenza (Influenza) 12/2022
1	COVID-19 related adult multisystem inflammatory disease 01/2022
1	Myocarditis (Carditis) 01/2022
1	COVID-19 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021

1	Third Generation CephalosporinsIBA 01/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2024
1	Antiviral Agents (Antivirals)IBA 12/2022
1	Oseltamivir (Tamiflu)FDA Link 12/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	anti-RNA-polymerase III autoantibodyIBA 01/2022
1	InterleukinsIBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022

2	Artificial Respiration (Mechanical Ventilation) 01/2024 - 01/2021
2	Extracorporeal Membrane Oxygenation 01/2022 - 01/2021
1	Therapeutics 01/2024
1	Mechanical Ventilators (Ventilator) 12/2022